Evidence map›Paper›PMID 32456643›Full record

ArticleMicrobial cell factories2020

Enhanced production of recombinant proteins in Corynebacterium glutamicum by constructing a bicistronic gene expression system.

Manman Sun, Xiong Gao, Zihao Zhao, An Li, Yali Wang, Yankun Yang, Xiuxia Liu, Zhonghu Bai

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Engineered membraneless organelles inSynthetic and systems biotechnology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Manman SunNational Engineering Laboratory of Cereal Fermentation Technology, Jiangnan University, Wuxi, 214112, China.
Xiong GaoDivision of Life Science and Center for Chinese Medicine, Hong Kong University of Science and Technology, Hong Kong, China.
Zihao ZhaoNational Engineering Laboratory of Cereal Fermentation Technology, Jiangnan University, Wuxi, 214112, China.
An LiNational Engineering Laboratory of Cereal Fermentation Technology, Jiangnan University, Wuxi, 214112, China.
Yali WangNational Engineering Laboratory of Cereal Fermentation Technology, Jiangnan University, Wuxi, 214112, China.
Yankun YangNational Engineering Laboratory of Cereal Fermentation Technology, Jiangnan University, Wuxi, 214112, China.
Xiuxia LiuNational Engineering Laboratory of Cereal Fermentation Technology, Jiangnan University, Wuxi, 214112, China. liuxiuxia@jiangnan.edu.cn.
Zhonghu BaiNational Engineering Laboratory of Cereal Fermentation Technology, Jiangnan University, Wuxi, 214112, China. baizhonghu@jiangnan.edu.cn.ORCID http://orcid.org/0000-0002-0995-034X
Jiangnan University · CNHong Kong University of Science and Technology · HK

Funding

National frst-class discipline program of Light Industry Technology and Engineering LITE2018-24Opening Project of Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education KLCCB-KF201911the 111 Project 111-2-06the National Natural Science Foundation of China 21808082the National Natural Science Foundation of China 21878124the National Natural Science Foundation of China 21938004
6 · The paper itself

Abstract

backgroundCorynebacterium glutamicum is a traditional food-grade industrial microorganism, in which an efficient endotoxin-free recombinant protein expression factory is under developing in recent years. However, the intrinsic disadvantage of low recombinant protein expression level is still difficult to be solved. Here, according to the bacteria-specific polycistronic feature that multiple proteins can be translated in one mRNA, efforts have been made to insert a leading peptide gene upstream of target genes as an expression enhancer, and it is found that this can remarkably improve the expression level of proteins under the control of inducible tac promoter in C. glutamicum.

resultsIn this research, the Escherichia coli (E. coli) tac promoter combined with 24 different fore-cistron sequences were constructed in a bicistronic manner in C. glutamicum. Three strong bicistronic expression vectors were isolated and exhibited high efficiency under different culture conditions. The compatibility of these bicistronic vectors was further validated using six model proteins- aldehyde dehydrogenase (ALDH), alcohol dehydrogenase (ADH), RamA (regulator of acetate metabolism), Bovine interferon-α (BoIFN-α), glycoprotein D protein (gD) of infectious bovine rhinotracheitis virus (IBRV) and procollagen type Ι N-terminal peptide (PΙNP). All examined proteins were highly expressed compared with the original vector with tac promoter. Large-scale production of PΙNP was also performed in fed-batch cultivation, and the highest PΙNP production level was 1.2 g/L.

conclusionIn this study, the strength of the inducible tac promoter for C. glutamicum was improved by screening and inserting fore-cistron sequences in front of the target genes. Those vectors with bicistronic expression patterns have strong compatibility for expressing various heterogeneous proteins in high yield. This new strategy could be used to further improve the performance of inducible promoters, achieving double competence of inducible control and high yield.

Indexed as

Corynebacterium glutamicumMetabolic EngineeringEscherichia coliGenetic VectorsPromoter Regions, GeneticProtein Sorting SignalsRecombinant ProteinsProtein Sorting SignalsRecombinant ProteinsBCD expression systemCorynebacterium glutamicumPΙNPRecombinant proteinScreening fore-cistron sequences

Identifiers

PMID32456643
PMCPMC7251831
OpenAlexW3029431812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.